Northwestern Mutual Wealth Management Co. acquired a new stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The fund acquired 15,615 shares of the semiconductor company’s stock, valued at approximately $6,965,000.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. Sankala Group LLC acquired a new position in shares of Synopsys in the 4th quarter valued at about $25,000. Elevation Wealth Partners LLC grew its stake in Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the period. Caitong International Asset Management Co. Ltd acquired a new stake in Synopsys during the fourth quarter worth approximately $28,000. IMG Wealth Management Inc. bought a new stake in Synopsys in the second quarter worth approximately $28,000. Finally, Atlas Capital Advisors Inc. bought a new stake in Synopsys in the fourth quarter worth approximately $32,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Analyst Ratings Changes
Several brokerages recently issued reports on SNPS. Weiss Ratings reissued a “hold (c-)” rating on shares of Synopsys in a research note on Monday, June 8th. Zacks Research raised shares of Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Benchmark reaffirmed a “buy” rating on shares of Synopsys in a research report on Wednesday. Wells Fargo & Company cut their price target on Synopsys from $535.00 to $450.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 11th. Finally, Piper Sandler upgraded Synopsys from a “neutral” rating to an “overweight” rating and boosted their price objective for the company from $450.00 to $550.00 in a report on Tuesday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Synopsys presently has an average rating of “Moderate Buy” and a consensus price target of $563.59.
Synopsys Price Performance
Shares of NASDAQ SNPS opened at $397.87 on Monday. The company has a market capitalization of $76.18 billion, a PE ratio of 92.10, a PEG ratio of 2.34 and a beta of 1.23. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The stock’s 50 day moving average price is $419.73 and its 200-day moving average price is $440.09. Synopsys, Inc. has a twelve month low of $366.00 and a twelve month high of $615.79.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s quarterly revenue was up 41.9% compared to the same quarter last year. During the same period last year, the company posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.
Insider Buying and Selling at Synopsys
In other news, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by corporate insiders.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
